These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 776078)

  • 1. [Antigenic properties of 1-asparaginases isolated from different species and strains of bacteria].
    Chaĭkovskaia SM; Makarova RA; Tochenaia NP; Frolova MA
    Antibiotiki; 1976 Mar; 21(3):255-8. PubMed ID: 776078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J; Schmid FA; Old LJ; Stockert E
    Cancer Biochem Biophys; 1976 May; 1(4):175-8. PubMed ID: 788892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships of bacterial L-asparaginases.
    Bascomb S; Bettelheim KA
    J Gen Microbiol; 1976 Jan; 92(1):175-82. PubMed ID: 54404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial L-asparaginase and glutamin(asparagin)ase: some properties, structure and anti-tumor activity].
    Sokolov NN; Zanin VA; Aleksandrova SS
    Vopr Med Khim; 2000; 46(6):531-48. PubMed ID: 11234278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cross-immunogenicity of various bacterial L-asparaginases].
    D'iakov IN; Pokrovskiĭ VS; Sannikova EP; Bulushova NV; Pokrovskaia MV; Aleksandrova SS
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):100-4. PubMed ID: 25816523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
    Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
    BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative experimental evaluation of immunodepressive and toxic effects of L-asparaginase (NSC-109229) from Escherichia coli and from Erwinia carotovora.
    Cavanna M; Celle G; Dodero M; Picciotto A; Pannacciulli I; Brambilla G
    Cancer Treat Rep; 1976 Mar; 60(3):255-7. PubMed ID: 769978
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the L-asparaginases from Escherichia coli and Erwinia carotovora as immunosuppressants.
    Ashworth LA; MacLennan AP
    Cancer Res; 1974 Jun; 34(6):1353-9. PubMed ID: 4596965
    [No Abstract]   [Full Text] [Related]  

  • 9. Mapping of B-cell epitopes in E. coli asparaginase II, an enzyme used in leukemia treatment.
    Werner A; Röhm KH; Müller HJ
    Biol Chem; 2005 Jun; 386(6):535-40. PubMed ID: 16006240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purification of microbial asparaginases by the aid of affinity chromatography].
    Mardashev SR; Nikolaev AIa; Kozlov EA; Petriĭ OP
    Biokhimiia; 1975; 40(1):78-82. PubMed ID: 1095078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the magnitude of Km and pH for L-asparaginase].
    Libinson GS; Mikhalev AV
    Biokhimiia; 1976 Jan; 41(1):149-52. PubMed ID: 6070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in the therapeutic, immunological, and clearance properties of Escherichia coli and Erwinia carotovora L-asparaginases by attachment of poly-DL-alanyl peptides.
    Uren JR; Ragin RC
    Cancer Res; 1979 Jun; 39(6 Pt 1):1927-33. PubMed ID: 376113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models.
    Avramis VI; Martin-Aragon S; Avramis EV; Asselin BL
    Anticancer Res; 2007; 27(4C):2561-72. PubMed ID: 17695416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of hepatotoxicity associated with antineoplastic asparaginases.
    Durden DL; Salazar AM; Distasio JA
    Cancer Res; 1983 Apr; 43(4):1602-5. PubMed ID: 6339039
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of the immunodepressive action of microbial deamidases from different sources].
    Kozlov EA; Tsvetkova TA
    Biull Eksp Biol Med; 1984 May; 97(5):565-7. PubMed ID: 6426545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation of an agglutinating anti-E. coli K 88+ serum].
    Petkov M; Belchev K; Ganovski D
    Vet Med Nauki; 1981; 18(1):27-31. PubMed ID: 6171087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
    Uren JR; Hargis BJ; Beardsley P
    Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic properties of bacterial L-asparaginase].
    Galaev IuV; Kharats KS; Spasov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Mar; 48(3):55-8. PubMed ID: 4932283
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of immunization to L-asparaginase on antitumor and enzymatic activity.
    Goldberg AI; Cooney DA; Glynn JP; Homan ER; Gaston MR; Milman HA
    Cancer Res; 1973 Feb; 33(2):256-61. PubMed ID: 4569788
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical review on properties and applications of microbial l-asparaginases.
    Krishnapura PR; Belur PD; Subramanya S
    Crit Rev Microbiol; 2016 Sep; 42(5):720-37. PubMed ID: 25865363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.